Education
About Us
Working with TipRanks
Follow Us
Verrica Pharmaceuticals (VRCA)
NASDAQ:VRCA
Earnings Data
Report Date
Feb 26, 2026TBA (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-0.76Last Year’s EPS
-2.4Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call highlighted significant growth in YCANTH dispensations, strategic partnerships, and positive regulatory feedback, offset by challenges like seasonality impacts and a lengthy EU filing process.Company Guidance
Significant Growth in YCANTH Dispensations
YCANTH dispensed applicator units increased by 120% year-over-year, reaching 37,642 units for the nine months ended September 30, 2025.
Strategic Partnership with Torii Pharmaceutical
Received $18 million in cash milestone payments from Torii in 2025, with $10 million received in the third quarter upon YCANTH's approval for molluscum in Japan.
Positive FDA Feedback for Basal Cell Carcinoma Asset VP-315
FDA provided clear and positive feedback on Phase III development for VP-315, showing a 97% objective response rate and an 86% reduction in tumor size.
EU Regulatory Milestone for YCANTH
Received feedback from the European Medicines Agency indicating no further Phase III studies are needed for filing a Marketing Authorization Application for YCANTH in the EU.
Financial Turnaround
Reported total revenue of $14.3 million in Q3 2025, compared to negative revenue of $1.8 million in Q3 2024.
VRCA Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
VRCA Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 14, 2025 | $3.93 | $3.73 | -5.09% |
Aug 12, 2025 | $6.82 | $6.59 | -3.37% |
May 13, 2025 | $5.50 | $5.35 | -2.73% |
Mar 11, 2025 | $6.48 | $5.99 | -7.56% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Verrica Pharmaceuticals (VRCA) report earnings?
Verrica Pharmaceuticals (VRCA) is schdueled to report earning on Feb 26, 2026, TBA (Confirmed).
What is Verrica Pharmaceuticals (VRCA) earnings time?
Verrica Pharmaceuticals (VRCA) earnings time is at Feb 26, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is VRCA EPS forecast?
VRCA EPS forecast for the fiscal quarter 2025 (Q4) is -0.76.